MUNDIPHARMA AS

1366 LYSAKER

Finances

Share Ownership

Return on Equity

2,71 %

Current Ratio

2,95

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	69 659 000	81 994 000	88 395 000	91 992 000
Net Income	1 661 000	1 963 000	2 049 000	2 014 000
Total Assets	92 399 000	79 138 000	75 668 000	68 455 000
Total Equity	61 368 000	59 707 000	57 744 000	55 695 000

Income (NOK)	2022	2021	2020	2019
Revenue	69 659 000	81 994 000	88 395 000	91 992 000
Expenditure	67 383 000	79 614 000	85 403 000	89 125 000
Operating Profit	2 276 000	2 379 000	2 991 000	2 868 000
Financial Income	52 000	172 000	424 000	184 000
Financial Costs	199 000	33 000	763 000	293 000
Financial Balance	−147 000	139 000	−339 000	−109 000
Earnings Before Tax	2 130 000	2 518 000	2 652 000	2 759 000
Tax	469 000	555 000	603 000	745 000
Net Income	1 661 000	1 963 000	2 049 000	2 014 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	931 000	439 000	1 387 000	1 748 000
Total Current Assets	91 469 000	78 699 000	74 281 000	66 707 000
Total Assets	92 399 000	79 138 000	75 668 000	68 455 000
Total Retained Equity	61 141 000	59 480 000	57 517 000	0
Total Equity	61 368 000	59 707 000	57 744 000	55 695 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	31 031 000	19 431 000	17 924 000	12 760 000
Total Equity and Debt	92 399 000	79 138 000	75 668 000	68 455 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	69 659 000	81 994 000	88 395 000	91 992 000
Other Income	0	0	0	0
Revenue	69 659 000	81 994 000	88 395 000	91 992 000
Cost of Goods Sold	61 181 000	71 512 000	44 205 000	45 774 000
Salary Costs	0	2 131 000	29 118 000	26 117 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	67 383 000	79 614 000	85 403 000	89 125 000
Operating Profit	2 276 000	2 379 000	2 991 000	2 868 000
Financial Income	52 000	172 000	424 000	184 000
Financial Costs	199 000	33 000	763 000	293 000
Financial Balance	−147 000	139 000	−339 000	−109 000
Dividends	0	0	0	0
Net Income	1 661 000	1 963 000	2 049 000	2 014 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	931 000	439 000	387 000	748 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	1 000 000	1 000 000
Total Fixed Assets	931 000	439 000	1 387 000	1 748 000
Stock	19 282 000	26 941 000	28 306 000	26 041 000
Total Investments	0	0	0	0
Cash, Bank	57 163 000	39 781 000	18 983 000	20 955 000
Total Current Assets	91 469 000	78 699 000	74 281 000	66 707 000
Total Assets	92 399 000	79 138 000	75 668 000	68 455 000
Total Equity	61 368 000	59 707 000	57 744 000	55 695 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	525 000	4 640 000	4 921 000	1 137 000
Unpaid Taxes	3 453 000	3 424 000	4 599 000	0
Dividends	0	0	0	0
Other Current Debt	25 884 000	10 759 000	8 163 000	11 623 000
Total Current Debt	31 031 000	19 431 000	17 924 000	12 760 000
Total Equity and Debt	92 399 000	79 138 000	75 668 000	68 455 000

Financial indicators	2022	2021	2020	2019
Return on Equity	2,71 %	3,29 %	3,55 %	3,62 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	3,27 %	2,9 %	3,38 %	3,12 %
Current Ratio	2,95	4,05	4,14	5,23
Quick Ratio	7,79	−10,48	−7,15	−5,02
Equity Ratio	0,66	0,75	0,76	0,81
Gross Profit Margin	12,17 %	12,78 %	49,99 %	50,24 %